Stock comparison
Lam Research
Novanta
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LRCX
Lam Research
Market cap
$385.48B
Sector
Technology
NOVT
Novanta
Market cap
$5.69B
Sector
Technology
Overall winner
Lam Research LRCX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LRCX | NOVT | Winner |
|---|---|---|---|
| Warren Buffett | 78B | 46D | LRCX |
| Benjamin Graham | 88A | 81A | LRCX |
| Philip Fisher | 76B | 39D | LRCX |
| Peter Lynch | 69B | 46D | LRCX |
| Joel Greenblatt | 84C | 42D | LRCX |
| Charlie Munger | 86A | 34F | LRCX |
| Terry Smith | 88A | 33F | LRCX |
Side-by-side metrics
| Metric | LRCX | NOVT |
|---|---|---|
| Market cap | $385.48B | $5.69B |
| P/E (TTM) | 55.4x | 105.3x |
| EV/EBIT | 62.9x | 41.9x |
| ROIC (TTM) | 42.79% | 5.33% |
| Gross margin | 49.98% | 44.23% |
| Net margin | 30.94% | 5.35% |
| Revenue CAGR 5y | 5.96% | 8.53% |
| EPS CAGR 5y | 11.27% | 0.87% |
| Debt / Equity | 0.4x | 0.2x |
| Dividend yield | 0.34% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LRCX leads on
- Dividend yield0.34%vs 0.0%+100%
- Market cap$385.48Bvs $5.69B+99%
- EPS CAGR 5y11.27%vs 0.87%+92%
- ROIC (TTM)42.79%vs 5.33%+88%
NOVT leads on
- Debt / Equity0.2xvs 0.4x+40%
- EV/EBIT41.9xvs 62.9x+33%
- Revenue CAGR 5y8.53%vs 5.96%+30%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.